DE VOS Pharma SRL
DE VOS Pharma reported total assets of €2.00m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026).
The score of DE VOS Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DE VOS Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
DE VOS Pharma's financial analysis
- Solvency43.4%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DE VOS Pharma
DE VOS Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0809.148.066
- VAT number
- BE0809148066
- Peppol
- Registered · 0208:0809148066 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jan 2009
- Registered office
- 2491 Balen
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
DE VOS Pharma (SRL) has been based in Balen since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 92,384 € and equity of 866,025 €; its revenue is not published. Its solvency stands at 43.4%, below the median of its sector (44.0%).
Companies similar to DE VOS Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Stef DE MAN Retail sale of pharmaceutical products Sint-Truiden · balance sheet €2.02m
- Gans Investors Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €1.97m
- APOTEEK P. Sergeant Retail sale of pharmaceutical products Anderlecht · balance sheet €1.95m
- Kevin BULKMANS Retail sale of pharmaceutical products Temse · balance sheet €1.93m
- Gerpinnes Pharma Retail sale of pharmaceutical products Gerpinnes · balance sheet €2.08m
- JUVO Retail sale of pharmaceutical products Oudenburg · balance sheet €1.89m
- GEOF Retail sale of pharmaceutical products Charleroi · balance sheet €2.10m
Frequently asked questions about DE VOS Pharma
What is the revenue of DE VOS Pharma?
DE VOS Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DE VOS Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0809148066 for DE VOS Pharma, if the company is VAT-registered. Its company number (CBE) is 0809.148.066.
Where is the registered office of DE VOS Pharma?
According to the CBE register, the registered office of DE VOS Pharma is in 2491 Balen.
What is the equity of DE VOS Pharma?
At the close of the 2025 financial year, the equity of DE VOS Pharma amounts to 866,025 €, a solvency of 43.4% of total assets.
Who manages DE VOS Pharma?
The register lists 3 active mandates at DE VOS Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DE VOS Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →